Dr. Reddy's Laboratories gains 2.4 pct.The generic drug maker remains confident of a faster resolution of US FDA observations at the Srikakulam plant - CLSA.Company in Nov. said it received some inspectional observations from US FDA on Srikakulam.
CLSA says one of its customers has received approval for a product, referencing a drug master file from this facility.Adds company has initiated site transfer for key products including generic Nexium to its own site.
For more news on Indian Stock Market Tips,Equity Market Tips please visit us at http://www.marketmagnify.com/services.php or call at 07316619100.
No comments:
Post a Comment